Contraception
Volume 75, Issue 6 , Pages 407-419, June 2007

Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV

  • Christine K. Mauck

      Affiliations

    • CONRAD, Eastern Virginia Medical School (EVMS), Arlington, VA 22209, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 703 276 3912; fax: +1 703 524 4770.
  • ,
  • Gustavo F. Doncel

      Affiliations

    • CONRAD, EVMS, Norfolk, VA 23507, USA
  • ,
  • Biomarkers of Semen Exposure Clinical Working Group

Received 16 August 2006; received in revised form 13 February 2007; accepted 23 February 2007. published online 10 May 2007.

Abstract 

Biomarkers of vaginal exposure to semen, long used in forensic medicine, are now becoming important in the development of vaginal microbicides to prevent HIV/STIs and the development of contraceptives. Semen biomarkers could help evaluate the safety of a new physical or chemical barrier, give preliminary indication of the effectiveness of physical barriers such as diaphragms or condoms, and provide information on unprotected intercourse among participants in a clinical trial who have been advised to use condoms. Candidate biomarkers of semen exposure fall into two broad categories: (1) biomarkers of seminal plasma, among which prostate-specific antigen (PSA) is the best characterized; and (2) biomarkers of spermatozoa and other cells present in semen. This paper, authored by a working group of investigators performing research in the field of semen biomarkers, summarizes the characteristics of an ideal semen biomarker, reviews preclinical and clinical data on existing and potential biomarkers, and outlines the steps that should be carried out to develop an improved biomarker of semen exposure.

Keywords: Biomarkers, Semen, STI pathogens

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 There was no funding since this paper is a review of the literature.

PII: S0010-7824(07)00116-3

doi:10.1016/j.contraception.2007.02.007

Contraception
Volume 75, Issue 6 , Pages 407-419, June 2007